Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SB-649915: Novel 5-HT1A receptor antagonist with potent 5-HT reuptake inhibitory activity

March 8, 2005

MPTP and calcium: novel targets for the treatment of Huntington's disease

March 8, 2005

Novel dopamine/noradrenaline/serotonin reuptake inhibitors imparted by NeuroSearch

March 7, 2005

Two series of serotonin reuptake inhibitors reported by Merck

March 4, 2005

New title added to the Drug R&D Backgrounders topic list - Autism Spectrum Disorders

March 4, 2005

NRP-104 reported effective in the treatment of ADHD

March 4, 2005

New phase II study for NeuroVax

March 4, 2005

Glycine transport inhibitors modulate dopamine in vitro

March 4, 2005

Neuroprotective effects of IBU-PO, a novel bifunctional NSAID-cholinesterase inhibitor

March 4, 2005

Non-approvable letter for Lexapro in panic disorder

March 3, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...